was read the article
array:21 [ "pii" => "X2013251406020144" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2006-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2006;26:426-32" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2576 "formatos" => array:3 [ "EPUB" => 212 "HTML" => 1842 "PDF" => 522 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699506020147" "issn" => "02116995" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2006-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2006;26:426-32" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4149 "formatos" => array:3 [ "EPUB" => 243 "HTML" => 3231 "PDF" => 675 ] ] "es" => array:10 [ "idiomaDefecto" => true "titulo" => "Albuminuria y riesgo cardiovascular. Estudio Koral-Cardio" "tienePdf" => "es" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "426" "paginaFinal" => "432" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Albuminuria and cardiovascular risk: results of the KORAL-CARDIO study" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.R. González-Juanatey, Eduardo Alegría Ezquerra, José Luis Zamorano Gómez, Vicente Bertomeu González, Olga Velasco Guijarro, Inmaculada" "autores" => array:1 [ 0 => array:1 [ "nombre" => "J.R. González-Juanatey, Eduardo Alegría Ezquerra, José Luis Zamorano Gómez, Vicente Bertomeu González, Olga Velasco Guijarro, Inmaculada" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251406020144" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251406020144?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699506020147?idApp=UINPBA000064" "url" => "/02116995/0000002600000004/v0_201502091329/X0211699506020147/v0_201502091329/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251406020179" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2006-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2006;26:433-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2956 "formatos" => array:3 [ "EPUB" => 243 "HTML" => 2027 "PDF" => 686 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Cystatin C as a renal function estimator in advanced chronic renal failure stages" "tienePdf" => "en" "tieneTextoCompleto" => 0 "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "433" "paginaFinal" => "438" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "CISTATINA C COMO ESTIMADOR DE LA FUNCIÓN RENAL EN ESTADIOS AVANZADOS DE ENFERMEDAD RENAL CRÓNICA" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M.V. Martín, S Barroso, O Herráez, F de Sande, F Caravaca" "autores" => array:1 [ 0 => array:1 [ "nombre" => "M.V. Martín, S Barroso, O Herráez, F de Sande, F Caravaca" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699506020171" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699506020171?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251406020179?idApp=UINPBA000064" "url" => "/20132514/0000002600000004/v0_201502091552/X2013251406020179/v0_201502091552/en/main.assets" ] "itemAnterior" => array:16 [ "pii" => "X2013251406019945" "issn" => "20132514" "estado" => "S300" "fechaPublicacion" => "2006-08-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2006;26:421-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2390 "formatos" => array:3 [ "EPUB" => 207 "HTML" => 1873 "PDF" => 310 ] ] "en" => array:6 [ "idiomaDefecto" => true "titulo" => "Cystatin C: Yes, but..." "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "421" "paginaFinal" => "425" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "CISTANINA C: SÍ, PERO..." ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Caravaca" "autores" => array:1 [ 0 => array:1 [ "nombre" => "F. Caravaca" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:8 [ "pii" => "X0211699506019948" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699506019948?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251406019945?idApp=UINPBA000064" "url" => "/20132514/0000002600000004/v0_201502091552/X2013251406019945/v0_201502091552/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Albuminuria and cardiovascular risk: results of the KORAL-CARDIO study" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "426" "paginaFinal" => "432" ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J.R. González-Juanatey, Eduardo Alegría Ezquerra, José Luis Zamorano Gómez, Vicente Bertomeu González, Olga Velasco Guijarro, Inmaculada" "autores" => array:1 [ 0 => array:1 [ "nombre" => "J.R. González-Juanatey, Eduardo Alegría Ezquerra, José Luis Zamorano Gómez, Vicente Bertomeu González, Olga Velasco Guijarro, Inmaculada" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Albuminuria y riesgo cardiovascular. Estudio Koral-Cardio" ] ] "pdfFichero" => "P-E-S-A1281-EN.pdf" "tienePdf" => true "PalabrasClave" => array:1 [ "es" => array:1 [ 0 => array:3 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec436480" ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "Introducción y objetivos: La presencia de albuminuria identifica a un grupo de hipertensos con mayor riesgo cardiovascular y renal y obliga a controlar mejor la presión arterial con fármacos que bloqueen el sistema renina-angiotensina. El objetivo del estudio KORAL-CARDIO fue determinar las características clínicas y de manejo de pacientes con hipertensión, albuminuria y cardiopatía no tratados previamente con inhibidores angiotensínicos. Pacientes y métodos: Se incluyen prospectivamente 2.711 pacientes (44% mujeres) de 64 años de media con hipertensión arterial, cardiopatía isquémica o hipertensiva o fibrilación auricular con positividad en la detección cualitativa de albuminuria. El 42% tenían además diabetes mellitus de tipo 2. Resultados: El 7,2% de los no diabéticos y el 12,7% de los diabéticos tenían macroalbuminuria; el 25% y el 35% respectivamente tenían índice de masa corporal de más de 30 kg/m2. Las complicaciones asociadas fueron: cardiopatía isquémica (22 y 39%), ictus (4 y 8%), fibrilación auricular (19 y 22%), hipercolesterolemia (42 y 53%), hipertensión de grado 3 (8% en ambos casos). Recibían tratamiento antihipertensivo monofármaco el 66% de los no diabéticos y el 63% de los diabéticos, y sólo el 7% triple terapia; otros tratamientos fueron: hipolipemiantes (41 y 57%) y antiagregantes (37 y 58% respectivamente). Conclusiones: Las complicaciones asociadas a la albuminuria en hipertensos con cardiopatías, diabéticos y no diabéticos, no tratados con inhibidores angiotensínicos son muy frecuentes. El grado de control tensional fue escaso en este grupo." ] "en" => array:1 [ "resumen" => "Background and objectives: Albuminuria is a marker of higher cardiovascular and renal risk in hypertension; it also indicates the need of a tighter control of blood pressure with drugs blocking the renin-angiotensin system. The objective of the KORAL-CARDIO study was to assess the clinical picture and management of patients with hypertension and cardiac disease and albuminuria not previously treated with angiotensin inhibitors. Methods: A total of 2,711 hypertensive patients (44% female) with ischemic or hypertensive cardiopathy or atrial fibrillation and with a positive screening test for albuminuria was included. Type 2 diabetes was also present in 42%. Results: Macroalbuminuria was present in 7.2% of non diabetic and 12.7% of diabetic patients, respectively. Associated complications were: 25% and 35% body mass index over 30 kg/m2; 22% and 39% ischemic heart disease; 4% and 8% stroke; 19% and 22% atrial fibrillation; 42% and 53% high cholesterol levels; 8% and 8% grade 3 hypertension, for non-diabetics and diabetics respectively. Antihypertensive monotherapy was used in 66% of non-diabetics and in 63% of diabetics; only 7% of patients in both groups were treated with triple antihypertensive therapy. Conclusions: Cardiovascular complications are very frequently associated to albuminuria in patients with hypertension and heart disease not previously treated with angiotensin inhibitors. Blood pressure control was clearly inadequate in this group." ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000002600000004/v0_201502091552/X2013251406020144/v0_201502091552/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002600000004/v0_201502091552/X2013251406020144/v0_201502091552/en/P-E-S-A1281-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251406020144?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 7 | 11 | 18 |
2024 October | 18 | 49 | 67 |
2024 September | 34 | 40 | 74 |
2024 August | 56 | 85 | 141 |
2024 July | 26 | 36 | 62 |
2024 June | 53 | 46 | 99 |
2024 May | 51 | 37 | 88 |
2024 April | 34 | 31 | 65 |
2024 March | 28 | 18 | 46 |
2024 February | 34 | 46 | 80 |
2024 January | 32 | 24 | 56 |
2023 December | 27 | 17 | 44 |
2023 November | 28 | 27 | 55 |
2023 October | 24 | 35 | 59 |
2023 September | 21 | 32 | 53 |
2023 August | 26 | 22 | 48 |
2023 July | 29 | 27 | 56 |
2023 June | 27 | 31 | 58 |
2023 May | 42 | 32 | 74 |
2023 April | 20 | 26 | 46 |
2023 March | 22 | 12 | 34 |
2023 February | 10 | 16 | 26 |
2023 January | 15 | 17 | 32 |
2022 December | 30 | 24 | 54 |
2022 November | 25 | 14 | 39 |
2022 October | 20 | 44 | 64 |
2022 September | 28 | 24 | 52 |
2022 August | 34 | 42 | 76 |
2022 July | 22 | 37 | 59 |
2022 June | 24 | 21 | 45 |
2022 May | 27 | 32 | 59 |
2022 April | 18 | 24 | 42 |
2022 March | 24 | 37 | 61 |
2022 February | 20 | 27 | 47 |
2022 January | 23 | 24 | 47 |
2021 December | 20 | 32 | 52 |
2021 November | 17 | 29 | 46 |
2021 October | 22 | 32 | 54 |
2021 September | 18 | 25 | 43 |
2021 August | 21 | 37 | 58 |
2021 July | 27 | 32 | 59 |
2021 June | 6 | 16 | 22 |
2021 May | 19 | 26 | 45 |
2021 April | 45 | 33 | 78 |
2021 March | 36 | 24 | 60 |
2021 February | 15 | 12 | 27 |
2021 January | 22 | 14 | 36 |
2020 December | 8 | 15 | 23 |
2020 November | 17 | 15 | 32 |
2020 October | 6 | 9 | 15 |
2020 September | 8 | 11 | 19 |
2020 August | 23 | 9 | 32 |
2020 July | 12 | 3 | 15 |
2020 June | 15 | 13 | 28 |
2020 May | 24 | 15 | 39 |
2020 April | 19 | 11 | 30 |
2020 March | 14 | 11 | 25 |
2020 February | 26 | 15 | 41 |
2020 January | 22 | 19 | 41 |
2019 December | 15 | 24 | 39 |
2019 November | 7 | 14 | 21 |
2019 October | 7 | 11 | 18 |
2019 September | 10 | 13 | 23 |
2019 August | 5 | 7 | 12 |
2019 July | 13 | 17 | 30 |
2019 June | 5 | 14 | 19 |
2019 May | 11 | 22 | 33 |
2019 April | 48 | 29 | 77 |
2019 March | 10 | 11 | 21 |
2019 February | 6 | 9 | 15 |
2019 January | 13 | 5 | 18 |
2018 December | 21 | 25 | 46 |
2018 November | 19 | 7 | 26 |
2018 October | 23 | 9 | 32 |
2018 September | 33 | 15 | 48 |
2018 August | 19 | 9 | 28 |
2018 July | 17 | 10 | 27 |
2018 June | 12 | 12 | 24 |
2018 May | 15 | 9 | 24 |
2018 April | 15 | 9 | 24 |
2018 March | 5 | 6 | 11 |
2018 February | 9 | 5 | 14 |
2018 January | 10 | 6 | 16 |
2017 December | 14 | 11 | 25 |
2017 November | 13 | 4 | 17 |
2017 October | 9 | 13 | 22 |
2017 September | 17 | 8 | 25 |
2017 August | 14 | 5 | 19 |
2017 July | 16 | 7 | 23 |
2017 June | 16 | 37 | 53 |
2017 May | 17 | 16 | 33 |
2017 April | 10 | 30 | 40 |
2017 March | 4 | 9 | 13 |
2017 February | 9 | 11 | 20 |
2017 January | 6 | 10 | 16 |
2016 December | 17 | 10 | 27 |
2016 November | 16 | 7 | 23 |
2016 October | 34 | 4 | 38 |
2016 September | 69 | 4 | 73 |
2016 August | 95 | 2 | 97 |
2016 July | 135 | 6 | 141 |
2016 June | 118 | 0 | 118 |
2016 May | 114 | 0 | 114 |
2016 April | 56 | 0 | 56 |
2016 March | 59 | 0 | 59 |
2016 February | 69 | 0 | 69 |
2016 January | 72 | 0 | 72 |
2015 December | 94 | 0 | 94 |
2015 November | 63 | 0 | 63 |
2015 October | 61 | 0 | 61 |
2015 September | 47 | 0 | 47 |
2015 August | 79 | 0 | 79 |
2015 July | 51 | 0 | 51 |
2015 June | 25 | 0 | 25 |
2015 May | 35 | 0 | 35 |
2015 April | 6 | 0 | 6 |